Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Suryakanth R. Gurudu"'
Autor:
Jean R. Kuo, Amy D. Davis, Eduardo A. Rodriguez, Marcelo F. Vela, Russell I. Heigh, Marcela A. Salomao, Suryakanth R. Gurudu
Publikováno v:
Case Reports in Gastroenterology, Vol 12, Iss 3, Pp 704-708 (2018)
Immune checkpoint inhibitors (ICPIs) are novel therapeutic agents targeting a variety of cancers by enhanced T cell activation. Immune-related adverse events (irAEs) commonly occur with ICPI use and can affect multiple organ systems including the gas
Externí odkaz:
https://doaj.org/article/53177bddbed44c9fafe6540271e56848
Publikováno v:
Case Reports in Gastroenterology, Vol 8, Iss 1, Pp 95-100 (2014)
Mycophenolate mofetil (MMF) is a commonly used drug in the prevention of allograft rejection in patients with solid organ transplants. Although diffuse colitis has been described in MMF-related colitis, segmental colitis has not been reported. We rep
Externí odkaz:
https://doaj.org/article/ca3a07422bff41a3a11e5fd7b058ebf6
Autor:
Lucinda A. Harris, Stephanie L. Hansel, Elizabeth Rajan, Komandoor Srivathsan, Robert Rea, Michael D. Crowell, David E. Fleischer, Shabana F. Pasha, Suryakanth R. Gurudu, Russell I. Heigh, Arthur D. Shiff, Janice K. Post, Jonathan A. Leighton
Publikováno v:
Gastroenterology Research and Practice, Vol 2013 (2013)
Background and Study Aims. The presence of an implantable electromechanical cardiac device (IED) has long been considered a relative contraindication to the performance of video capsule endoscopy (CE). The primary aim of this study was to evaluate th
Externí odkaz:
https://doaj.org/article/77583f15377d4fdfa8acca41113d2593
Autor:
Niloy Jewel Samadder, Luke Mountjoy, Blanca Lizaola-Mayo, Michael A. Golafshar, Tanio S. Bekaii-Saab, Katie L. Kunze, Douglas L. Riegert-Johnson, Harminder Singh, Suryakanth R. Gurudu, Neej J. Patel, Pedro L.S. Uson, Margaret Klint, Lisa A. Boardman, John B. Kisiel, Jeremy Clifton Jones, Jonathan A. Leighton, Daniel H. Ahn, Mohamad Bassam Sonbol, A. Keith Stewart, Ed D. Esplin, Mitesh J. Borad, Robert L. Nussbaum
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:e508-e528
Background & Aims Hereditary factors play a role in the development of colorectal cancer (CRC). Identification of germline predisposition can have implications on treatment and cancer prevention. This study aimed to determine the prevalence of pathog
Autor:
Mio Matsumoto, Femke Atsma, Maximilien Barret, Jochim S. Terhaar sive Droste, F. Desideri, Gijs Kemper, Chun-Wei Chen, Kazutomo Togashi, Wey-Ran Lin, Romain Coriat, Erwin J M van Geenen, Peter D. Siersema, Sarah B. Umar, Karl Kwok, Eduardo Albéniz, Daniel G. Luba, Brian Lim, Ruud W. M. Schrauwen, Gottumukkala S. Raju, Ayla S. Turan, Douglas K. Rex, Suryakanth R. Gurudu, Heiko Pohl, Masato Aizawa, Brian S. Lee, Francisco C. Ramirez
Publikováno v:
Clinical Gastroenterology and Hepatology, 20, 2, pp. 362-371
Clinical Gastroenterology and Hepatology, 20, 362-371
Clinical Gastroenterology and Hepatology, 20, 362-371
Background & Aims Nonpedunculated colorectal polyps are normally endoscopically removed to prevent neoplastic progression. Delayed bleeding is the most common major adverse event. Clipping the resection defect has been suggested to reduce delayed ble
Autor:
Robert J. Mayer, Folasade P. May, Kathryn M. Glaser, Jennifer M. Weiss, Lillias H. Maguire, Reid M. Ness, Shivan J. Mehta, Swati G. Patel, Rishi Jain, Priyanka Kanth, Amy L. Halverson, Trilokesh D. Kidambi, Dayna S. Early, Mark Friedman, Ndiya Ogba, Francis M. Giardiello, Mary A. Dwyer, Audrey J. Lazenby, Arnold J. Markowitz, Gregory S. Cooper, Xavier Llor, Shajan Peter, Jennifer Keller, Jonathan P. Terdiman, Rachel B. Issaka, Peter P. Stanich, Dawn Provenzale, Suryakanth R. Gurudu, Benjamin Abbadessa
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:1312-1320
The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physi
Autor:
Stephanie L. Hansel, Crystal Lavey, Prasad G. Iyer, Joseph A. Murray, Elizabeth Rajan, Badr Al Bawardy, Suryakanth R. Gurudu, Manuel Martinez, Shabana F. Pasha, Jonathan A. Leighton, Arthur D. Shiff, Emmanuel C. Gorospe, David H. Bruining, Cadman L. Leggett, Chien-Huan Chen, Kristin C. Mara, Akira Dobashi, Vandana Nehra, Laura E. Raffals, David A. Katzka
Publikováno v:
Gastrointestinal Endoscopy. 91:1140-1145
Background and Aims Capsule endoscopy (CE) is an established, noninvasive modality for examining the small bowel. Minimum training requirements are based primarily on guidelines and expert opinion. A validated tool to assess the competence of CE is l
Autor:
David O. Prichard, Eduardo A. Rodriguez, Sara Then, Kelli N. Burger, Douglas W. Mahoney, Kari L. Lowrie, Allon Kahn, Lila J. Finney, Jamie Bering, Jason D. Eckmann, David A. Ahlquist, John B. Kisiel, Karen A. Doering, Derek Ebner, Mary E. Devens, Paul J. Limburg, Barry M. Berger, Michael B. Wallace, Suryakanth R. Gurudu
Publikováno v:
The American Journal of Gastroenterology
OBJECTIVES: Multitarget stool DNA (MT-sDNA) testing has grown as a noninvasive screening modality for colorectal cancer (CRC), but real-world clinical data are limited in the post-FDA approval setting. The effect of previous colonoscopy on MT-sDNA pe
Autor:
David O. Prichard, Kelli N. Burger, Allon Kahn, Jason D. Eckmann, Eduardo A. Rodriguez, Douglas W. Mahoney, Sunanda V. Kane, John B. Kisiel, Suryakanth R. Gurudu, Jamie Bering, Michael B. Wallace, Derek Ebner, Lila J. Finney Rutten
Publikováno v:
Clinical and Translational Gastroenterology
Introduction Significant variability between colonoscopy operators contributes to postcolonoscopy colorectal cancers (CRCs). We aimed to estimate postcolonoscopy colorectal neoplasia (CRN) detection by multi-target stool DNA (mt-sDNA), which has not
Autor:
Haider Al Taii, Yash Jobanputra, Madhusudhan R. Sanaka, Suryakanth R. Gurudu, Vaibhav Wadhwa, Rocio Lopez, Prashanthi N. Thota
Publikováno v:
Surgical Endoscopy. 34:325-331
Adenoma detection rate (ADR), a validated quality indicator (QI) of colonoscopy, does not take into account risk stratification of adenomas. Low-risk adenomas are not associated with a significantly increased risk of future colorectal cancer (CRC). O